
Loading, please wait...

Loading, please wait...

The AIIMS Delhi leadership transition began recently after the appointment of Dr. M Srinivas as a member of NITI Aayog. Consequently, the institute expects to name an interim director before the government appoints a full-time head. This move creates a temporary vacancy at the helm of India's premier medical institution. Currently, officials remain focused on ensuring administrative continuity during this period of change.
Selection of a permanent director typically takes several months. Therefore, the institute often relies on the senior-most faculty member to lead in the interim. This approach follows established conventions within the organization. While the government aims to move quickly, the rigorous selection process for a full-time leader requires significant time and deliberation. Furthermore, internal leadership remains a traditional preference for the institute.
Several names are currently circulating within the medical community. For instance, Dr. Nikhil Tandon, head of endocrinology, and Dr. Radhika Tandon, Professor of Ophthalmology, are prominent figures. Additionally, Prof. Sandeep Chauhan, head of cardiac anesthesia, is also mentioned as a potential candidate. However, sources caution that the government has not finalized any decision yet. The senior-most person usually holds the charge until a formal appointment occurs.
Dr. M Srinivas took charge in September 2022, succeeding Dr. Randeep Guleria. His tenure saw the institute navigate challenges such as a significant ransomware attack on its servers. Despite this, he maintained stability across departments. Historically, AIIMS Delhi favors leaders who have risen through its own ranks. Although Dr. Srinivas had prior links to the institute, his selection came from a wider panel considered by the Appointments Committee of Cabinet.
Q1: Why is AIIMS Delhi appointing an interim director?
AIIMS Delhi needs an interim head because the current director, Dr. M Srinivas, has been appointed as a member of NITI Aayog. A full-time appointment may take several months to finalize.
Q2: Who is typically chosen as the interim director at AIIMS?
According to established conventions, the senior-most faculty member is usually asked to hold the charge until a permanent director is selected.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AIIMS Delhi seeks an interim director following Dr M Srinivas’s move to NITI Aayog. Explore the transition process and the potential senior faculty candidat...
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today